Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1 Dose Escalation and Expansion Study of XB628 as a Single Agent and in Combination With Zanzalintinib in Participants With Advanced or Metastatic Solid Tumors

This study consists of a Dose-Escalation stage and a Dose Expansion stage. The primary purpose of the dose escalation stage is to determine the maximum tolerat…

Solid TumorAdvanced Solid TumorMetastatic Solid Tumor+1 more

Estimated

~$10 – $7,500

ExelixisNCT06952010